Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'. Nat Rev Clin Oncol. 2018 Feb 13;: Authors: Neelapu SS, Tummala S, Kebriaei P, Wierda W, Locke FL, Lin Y, Jain N, Daver N, Gulbis AM, Adkins S, Rezvani K, Hwu P, Shpall EJ PMID: 29434334 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29434334?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - February 13, 2018 Category: Cancer & Oncology Authors: Neelapu SS, Tummala S, Kebriaei P, Wierda W, Locke FL, Lin Y, Jain N, Daver N, Gulbis AM, Adkins S, Rezvani K, Hwu P, Shpall EJ Tags: Nat Rev Clin Oncol Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma | Toxicology